Adhesive small bowel obstruction (ASBO) is commonly managed conservatively, with adjuncts such as CT scan with per-oral water-soluble contrast, which are diagnostic and in some cases therapeutic. However, these may not be consistently available in low-resource settings. Hypertonic solutions have been shown to influence intestinal oedema and function, but the role of intravenous hypertonic dextrose is unclear. We describe an observational experience of adjunctive 25% dextrose (40 mL daily for 3 days) in selected patients with ASBO managed non-operatively at a tertiary centre in central India.
LeeMJSayersAEDrakeTM, et al.NASBO Steering group and NASBO collaborators. National prospective cohort study of the burden of acute small bowel obstruction. BJS Open2019; 3: 354–366.
2.
JenaSSObiliRCRDasSAP, et al.Intestinal obstruction in a tertiary care centre in India: are the differences with the western experience becoming less?Ann Med Surg (Lond)2021; 72: 103125.
3.
Ten BroekRPGKrielenPDi SaverioS, et al.Bologna Guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg2018; 13: 24.
4.
KohAAdiamahAChowdhuryA, et al.Therapeutic role of water-soluble contrast Media in adhesive small bowel obstruction: a systematic review and meta-analysis. J Gastrointest Surg2020; 24: 473–483.
5.
ColemanEP. Use of hypertonic saline solution in acute intestinal obstruction – personal observations. JAMA1927; 88: 1060–1062.
6.
TitusP. Preoperative and postoperative therapeutic use of dextrose (glucose). Am J Surg1930; 8: 1196–1200.
7.
RasslanRUtiyamaEMMarquesGM, et al.Inflammatory activity modulation by hypertonic saline and pentoxifylline in a rat model of strangulated closed loop small bowel obstruction. Int J Surg2014; 12: 594–600.